Adelene Q. Perkins, Director at INFINITY PHARMACEUTICALS, INC. (INFI), sold 410,196 shares at $0.07 ($29K) on 2023-09-12, disclosed to the SEC on 2023-09-12.
Scheduled sale ($29k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| INFI | SELL | 2015-06-26 | $55K | — | Filing → |
| INFI | SELL | 2015-05-28 | $128K | — | Filing → |
| INFI | SELL | 2015-05-15 | $122K | — | Filing → |